Three-year follow up of adrenal incidentalomas in a New Zealand centre.
To follow up at least 100 patients for 3 years who were originally found to have benign adrenal adenomas which were non-functional or had subclinical Cushing's syndrome (SCS). This study prospectively evaluated consecutive patients aged 18 years or older with benign adrenal incidentalomas (AI), not treated with adrenalectomy, which were non-functioning or had SCS. The initial and follow up evaluation, including clinical assessment, hormonal investigations and imaging were coordinated via a standardised nurse-led AI clinic. Of 233 patients referred to the AI clinic, 101 patients met the inclusion criteria and completed 3-year follow up. Most of those excluded were due to incomplete initial or follow-up evaluation, or were not true AI. Most AI either remained stable or decreased in size on repeat imaging, whilst 5% of patients had AI enlargement of >5mm diameter. No patient developed features suggesting adrenal carcinoma. Ninety-two patients had an initial diagnosis of non-functioning adenoma and nine patients had SCS. After three years (range 2.9-4.7 years), 5 of the 9 patients with SCS showed normalisation of cortisol parameters (44%), and 5 of the 92 non-functional AI patients developed SCS (5%). After three years of follow-up, approximately half of patients with SCS normalised, while 5% of patients with initially non-functioning adenomas developed biochemical evidence of SCS. This study found a low likelihood of progressive hormonal excess with no evidence of malignancy developing on follow-up evaluation, providing support for the shift towards the more conservative approach to management of AI recommended in recent guidelines. This article is protected by copyright. All rights reserved.